Researchers say a new drug-delivery implant could help patients with hard-to-treat bladder cancer avoid losing their bladders — and stay cancer-free for years.

Park says patient-specific factors that influence his treatment selection include the presence of liver disease, ...

Bladder cancer is the ninth most common cancer in the world, the fourth most common cancer in men, and the 11th most common ...

ESMO 2025 bladder cancer highlights include results from KEYNOTE-905/EV-303, RC48-C016, and IMvigor011 studies.

Bladder cancer was diagnosed through cystoscopy, with initial treatment involving surgery and Bacillus Calmette-Guérin immunotherapy. Recurrence required further surgery. Shared exposure to ...

Supplementing standard of care with multi-cancer testing increased diagnoses by just 2.8%, suggesting overdiagnosis is not a ...